Author

Pradeep Das

Rajendra Memorial Research Institute of Medical Sciences (ICMR) - Cited by 9,138 - Parasitology - Immunology - Molecular Biology

Biography

Pradeep Das is currently working at Rajendra Memorial Research Institute of Medical Sciences from 2005. He completed his higher education (Doctor of Medicine) at Central Drug Research Institute-Lucknow from 1978 to 1981. He achieved his Membership at Life Society for Biological Chemists of India (Life Member).
Title
Cited by
Year
DDT-based indoor residual spraying suboptimal for visceral leishmaniasis elimination in India
M Coleman, GM Foster, R Deb, R Pratap Singh, HM Ismail, P Shivam, ...Proceedings of the National Academy of Sciences 112 (28), 8573-8578, 2015201
95
2015
Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani
R Kumar, GC Sahoo, K Pandey, VNR Das, P DasDrug delivery 22 (3), 383-388, 2015201
74
2015
Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome)
S Burza, R Mahajan, PK Sinha, J van Griensven, K Pandey, MA Lima, ...PLoS neglected tropical diseases 8 (8), e3053, 2014201
69
2014
Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India
MM Cameron, A Acosta-Serrano, C Bern, M Boelaert, M Den Boer, ...Parasites & vectors 9 (1), 1-9, 2016201
64
2016
Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani
P Bhattacharya, S Ghosh, SA Ejazi, M Rahaman, K Pandey, VN Ravi Das, ...PLoS Neglected Tropical Diseases 10 (2), e0004422, 2016201
64
2016
Phlebotomus argentipes Seasonal Patterns in India and Nepal
A Picado, ML Das, V Kumar, DS Dinesh, S Rijal, SP Singh, P Das, ...Journal of medical entomology 47 (2), 283-286, 2014201
53
2014
Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label study
S Sundar, K Pandey, CP Thakur, TK Jha, VNR Das, N Verma, CS Lal, ...PLoS Neglected Tropical Diseases 8 (9), e3169, 2014201
50
2014
Prevalence of malaria infection and risk factors associated with anaemia among pregnant women in semiurban community of Hazaribag, Jharkhand, India
M Sohail, S Shakeel, S Kumari, A Bharti, F Zahid, S Anwar, KP Singh, ...BioMed research international 2015, 2015201
49
2015
Deprivation of L-Arginine Induces Oxidative Stress Mediated Apoptosis in Leishmania donovani Promastigotes: Contribution of the Polyamine Pathway
A Mandal, S Das, S Roy, AK Ghosh, AH Sardar, S Verma, S Saini, ...PLOS Neglected Tropical Diseases 10 (1), e0004373, 2016201
48
2016
Development of PLGA–PEG encapsulated miltefosine based drug delivery system against visceral leishmaniasis
R Kumar, GC Sahoo, K Pandey, VNR Das, RK Topno, MY Ansari, S Rana, ...Materials Science and Engineering: C 59, 748-753, 2016201
42
2016
Metabolic reconfiguration of the central glucose metabolism: a crucial strategy of Leishmania donovani for its survival during oxidative stress
AK Ghosh, AH Sardar, A Mandal, S Saini, K Abhishek, A Kumar, B Purkait, ...The FASEB Journal 29 (5), 2081-2098, 2015201
42
2015
Ascorbate peroxidase, a key molecule regulating amphotericin B resistance in clinical isolates of Leishmania donovani
A Kumar, S Das, B Purkait, AH Sardar, AK Ghosh, MR Dikhit, K Abhishek, ...Antimicrobial agents and chemotherapy 58 (10), 6172-6184, 2014201
40
2014
Establishment of correlation between in-silico and in-vitro test analysis against Leishmania HGPRT to inhibitors
MY Ansari, A Equbal, MR Dikhit, R Mansuri, S Rana, V Ali, GC Sahoo, ...International journal of biological macromolecules 83, 78-96, 2016201
37
2016
Research priorities for elimination of visceral leishmaniasis
G Matlashewski, B Arana, A Kroeger, A Be-Nazir, D Mondal, SG Nabi, ...The Lancet Global Health 2 (12), e683-e684, 2014201
34
2014
Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani
B Purkait, R Singh, K Wasnik, S Das, A Kumar, M Paine, M Dikhit, D Singh, ...Journal of Antimicrobial Chemotherapy 70 (5), 1343-1356, 2015201
33
2015
Asymptomatic Leishmania infections in northern India: a threat for the elimination programme?
S Das, G Matlashewski, GS Bhunia, S Kesari, P DasTransactions of the Royal Society of Tropical Medicine and Hygiene 108 (11 …, 2014201
32
2014
Up-regulation of cytosolic tryparedoxin in Amp B resistant isolates of Leishmania donovani and its interaction with cytosolic tryparedoxin peroxidase
SS Suman, A Equbal, A Zaidi, MY Ansari, KP Singh, K Singh, B Purkait, ...Biochimie 121, 2-325, 2016201
31
2016
Stage-dependent expression and up-regulation of trypanothione synthetase in amphotericin B resistant Leishmania donovani
A Equbal, SS Suman, S Anwar, KP Singh, A Zaidi, AH Sardar, P Das, V AliPloS one 9 (6), e97600, 2014201
29
2014
Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral …
A Yadav, A Amit, R Chaudhary, AS Chandel, V Mahantesh, SS Suman, ...International journal for parasitology 45 (1), 33-42, 2015201
28
2015
Computational elucidation of potential antigenic CTL epitopes in Ebola virus
MR Dikhit, S Kumar, BR Sahoo, R Mansuri, A Amit, MY Ansari, GC Sahoo, ...Infection, Genetics and Evolution 36, 369-375, 2015201
28
2015

Referred From: https://scholar.google.co.in/citations?user=0pZS3-cAAAAJ&hl=en

Cited by
Citations 9138
h-index 50
i10-index 173
Open Access Journals